The United Therapeutics Corporation (UTHR) gross profit margin is 88.9%, compared to the industry median of 64.9% and the 5-year historical average of 91.5%.
The United Therapeutics Corporation (UTHR) operating income margin is 52.2%, compared to the industry median of (879.7%)) and the 5-year historical average of 42.9%.
The United Therapeutics Corporation (UTHR) Free Cash Flow margin is 32.6%, compared to the industry median of (720.0%) and the 5-year historical average of 33.1%.
The United Therapeutics Corporation (UTHR) earnings quality is 80.8%, compared to the industry median of 83.4% and the 5-year historical average of 111.3%.